skip to main content
Partner - Adam M. Masin

Adam M. Masin


Download vCard

Adam Masin represents nationally recognized health care institutions, pharmaceutical companies, and medical device manufacturers in product liability, medical negligence, and commercial litigation. Adam has litigated complex medical and product liability issues in numerous Multi-District Litigations (MDLs), consolidated state actions, and individual lawsuits in many federal and state jurisdictions. His experience includes cases involving drugs, devices, nutritional supplements, and medical issues related to neonatology, cardiology, oncology, urogynocology, orthopedics, mycology, hematology, neuropsychology, internal medicine, primary care, and a range of other medical specialties. He also counsels companies on FDA issues, risk management, and investigations.

Adam serves on the Board of Directors of the NEC Society, the leading US nonprofit dedicated to the understanding and prevention of necrotizing enterocolitis. He regularly volunteers for the Just The Beginning - A Pipeline Organization Summer Legal Institute Moot Court program. Adam's pro bono work has included advising a nonprofit education advocacy group, successfully winning a client’s home back in a tangled title case, and providing advice to a Brazilian nonprofit environmental foundation.

Adam’s experience includes:

  • Obtained complete defense victory as trial counsel for a world-class Connecticut hospital in a product liability lawsuit involving the use of probiotics to prevent necrotizing enterocolitis.

  • Prepared expert medical witnesses for deposition and trial testimony in the Hip Implant Products MDL.

  • Handled all case-specific discovery in one of four MDL Bellwether trial cases for a female pelvic mesh manufacturer. Adam has handled case-specific discovery in dozens of individual pelvic mesh lawsuits.

  • Obtained a favorable eight-figure settlement on behalf of an international pharmaceutical manufacturer in a commercial litigation involving the U.S. marketing of their branded drug.

  • Obtained complete trial court and Second Circuit victories in Megna v. Food and Drug Administration, a product liability lawsuit involving Interferon.

  • Obtained complete trial court and Sixth Circuit victories in a diet drug lawsuit, Montgomery v. Wyeth, based on the Tennessee statute of repose, and successfully defended a collateral attack on the judgment in the MDL Court.

  • Obtained complete trial court and appellate victories in Nelson v. Wyeth, the first hormone therapy case to go to trial in the Philadelphia Court of Common Pleas.

  • Obtained complete trial court and appellate victories in Cochran v. Wyeth, setting Pennsylvania precedent that a failure to warn claim cannot be based on injuries the plaintiff did not have.

  • Briefed Wyeth’s summary judgment motion in Bailey v. Wyeth, which held Wyeth’s hormone therapy warnings to be adequate as a matter of New Jersey law and resulted in dismissal of hundreds of cases.

Adam also counsels Brazilian individuals and businesses on issues involving U.S. law and draws on a wealth of contacts in Brazil to handle cross-border issues. 

Adam earned his B.A. from the University of Wisconsin-Madison in 1995 and his J.D. from Fordham University School of Law in 2000, where he was awarded the John J. McKay Prize for Excellence in Oral Advocacy and selected to the National Moot Court team. He was also selected to the Criminal Defense Clinic and was a member of the Fordham International Law Journal. He served as a judicial intern to U.S. Magistrate Arlene R. Lindsay of the Eastern District of New York.


  • Member of the Legal 500 Product Liability Defense Litigation “Team of the Year” (2014)
  • Member of The American Lawyer "Product Liability Litigation Department of the Year" (2010)
  • Fordham International Law Journal, Member

Professional Affiliations

  • DRI, The Voice of the Defense Bar
  • American Bar Association: Section of Litigation
  • Connecticut Bar Association
  • Brazilian-American Chamber of Commerce

Community Involvement

  • NEC Society: Member, Board of Directors (2019)

Megna v. Food and Drug Administration, et aI., 09-1919-cv, (2d Cir. May 18, 2010)

Affirming the Eastern District of New York's decision granting Schering-Plough's motion to dismiss.

Montgomery v. Wyeth, 580 F.3d 455 (6th Cir. 2009)

Affirming.540 F.Supp.2d 933 (E.D. Tenn. 2008). Granting summary judgment for Wyeth based on the Tennessee statute of repose.


Your e-mail and any information in your e-mail to this individual are not protected by the attorney client privilege. Therefore your e-mail should not contain any confidential information and should be for general information purposes only. The e-mail to this individual is not intended to create, and does not constitute, an attorney-client relationship.

Practice Areas

Industries & Featured Services


  • Fordham University School of Law, J.D., 2000
  • University of Wisconsin - Madison, B.A., 1995

Bar Admissions

  • New York
  • Connecticut

Court Admissions

  • U.S. District Court, Southern District of NY
  • U.S. District Court, District of CT
© Shipman & Goodwin LLP 2019. All Rights Reserved.